Zhou qing

Ms. Zhou qing

Huzhou Central Hospital

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2020 in Journal of Intensive Care
Verified
Journal Article
Open access
PDF file
LZLei Zhong
Lei Zhong
XJXiao-Wei Ji
Xiao-Wei Ji
HWHai-Li Wang
Hai-Li Wang
GZGuang-Ming Zhao
Guang-Ming Zhao
ZQZhou qing
Zhou qing
BXBo Xie
Bo Xie
Background: Norepinephrine (NE) has currently been the first-choice vasopressor in treating septic shock despite generally insufficient for patients with refractory septic shock. The aim of this update meta-analysis was to assess the safety and efficacy of a combination of non-catecholamine vasopressors (vasopressin/pituitrin/terlipressin/selepressin/angiotensin II) and NE versus NE in managing adult septic shock patients. Methods: We conducted this study of literatures published from the inception to April 30, 2020, using PubMed, Embase, and the Cochrane Library databases without language restriction. Randomized controlled trials comparing NE with non-catecholamine vasopressors among adult septic shock patients were included in this meta-analysis. Pooled effects of relative risk (RR) or standard mean difference (SMD) and corresponding 95% confidence interval (CI) were calculated using a random-effects model. Results: Twenty-three studies covering 4380 participants were finally enrolled. The combined analysis of non-catecholamine vasopressors resulted in a nonsignificant reduction in 90-day/ICU/hospital mortality except for a decreased in 28-day mortality (n = 4217; RR, 0.92; 95% CI 0.86–0.99; P = 0.02). This favorable result was subsequently verified by the subgroup analyses of low risk of bias studies (RR = 0.91, 95% CI = 0.84 to 0.98; P = 0.02) and catecholamine-resistant refractory shock patients group (RR, 0.84; 95% CI = 0.70–1.00; P = 0.048). The pooled analysis of non-catecholamine vasopressors showed a 14% higher success rate of shock reversal at 6 h, a 29% decreased risk of continuous renal replacement therapy, but a 51% increased risk of hyponatremia and a 2.43 times higher risk of digital ischemia. Besides, the pooled data showed that non-catecholamine vasopressors decreased heart rate (HR) (SMD, − 0.43; 95% CI − 0.66 – − 0.19; P < 0.001), serum creatinine (− 0.15; 95% CI − 0.29 – − 0.01; P = 0.04), and the length of mechanical ventilation (MV) (− 0.19; 95% CI − 0.31 – − 0.07; P < 0.01, but there was no significant difference in other parameters. Conclusions: Current pooled results suggest that the addition of NE to non-catecholamine vasopressors was associated with a marginally significant reduction in 28-day mortality. Moreover, they were able to shorten the length of MV, improved renal function, decreased HR, and increased the 6-h shock reversal success rate at the expense of increased the risk of hyponatremia and digital ischemia.

18 November 2025 in Frontiers in Psychiatry
Verified
Journal Article
Open access
YZYu Zhang
Yu Zhang
XYXinyu Yang
Xinyu Yang
QGQingxin Gu
Qingxin Gu
JPJiawen Pan
Jiawen Pan
JMJia Mao
Jia Mao
LZLixiu Zhang
Lixiu Zhang
Objective: To explore the relationship between living space, cognitive function, anxiety, and depression in ischemic stroke patients, specifically examining the mediating roles of anxiety and depression. Methods: A cross-sectional study included 445 ischemic stroke patients treated in the neurology department of a top-tier hospital in Zhejiang Province and discharged between January 2024 and January 2025 were selected. Participants completed General information questionnaires, the Montreal Cognitive Assessment (MoCA), Living Space Scale, and Hospital Anxiety and Depression Scale (HADS). Data were analyzed using R4.4.2 and MPLUS 8.7 software. Results: Among 445 participants, correlation analysis showed that cognitive function was positively correlated with living space ( r = 0.37, P < 0.05) and negatively correlated with anxiety symptoms and depression symptoms ( r = -0.53, r = -0.64, all P < 0.05). Anxiety and depression were mediating variables between living space and cognitive function ( 95%CI : 0.018~0.117, 0.017~0.095), with effect sizes of 0.072 and 0.057, respectively. Additionally, anxiety and depression played a serial mediating role between living space and cognitive function ( 95%CI : 0.082~0.172), with an effect sizes of 0.122. Conclusion: Living space level directly affect the cognitive function in ischemic stroke patients and indirectly affects cognition through its impact on psychological health, mediated independently and serially by anxiety and depression.

7 April 2026 in BMC Psychology
Verified
Journal Article
Open access
PDF file
YZYu Zhang
Yu Zhang
JLJialin Lv
Jialin Lv
XYXinyu Yang
Xinyu Yang
JPJiawen Pan
Jiawen Pan
JMJia Mao
Jia Mao
WWWenqian Weng
Wenqian Weng
To investigate the longitudinal developmental trajectories and bidirectional predictive relationships between professional identity and future self-continu